Rockefeller Capital Management
LEGN icon

Rockefeller Capital Management’s Legend Biotech LEGN Stock Holding History

Rockefeller Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.5M Buy
83,178
+83,122
+148,432% +$1.58M ﹤0.01% 1423
2025
Q4 		$1.23K Buy
56
+37
+195% +$1.06K ﹤0.01% 4418
2025
Q3 		$620 Buy
+19
New +$702 ﹤0.01% 4244
2022
Q1 		– Sell
-1,000
Closed -$46K – 3982
2021
Q4 		$46K Sell
1,000
-500
-33% -$25.4K ﹤0.01% 2258
2021
Q3 		$75K Buy
+1,500
New +$62.4K ﹤0.01% 1984

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Rockefeller Capital Management's LEGN Position: Q1 2026 in Review

Rockefeller Capital Management increased its Legend Biotech (LEGN) stake by 148,432% in Q1 2026, buying an estimated $1.58M and bringing the position to 83,178 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Rockefeller Capital Management first reported a position in LEGN in Q3 2021 and has held it in 5 quarters since. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Rockefeller Capital Management held 83,178 shares of Legend Biotech worth $1.5M as of Q1 2026.
  • Rockefeller Capital Management bought 83,122 Legend Biotech shares in Q1 2026, an estimated $1.58M.
  • Legend Biotech made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1423 holding.
  • Rockefeller Capital Management first reported a position in Legend Biotech in Q3 2021 and has held it in 5 quarters since.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.